7 news items
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUL
6 May 24
approved by the Compensation Committee of Ocular and were made as inducements material to each individual's acceptance of employment with Ocular
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
OCUL
3 May 24
Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
OCUL
1 May 24
results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Such forward-looking
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
OCUL
18 Apr 24
Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
OCUL
16 Apr 24
may differ materially from those indicated by such forward-looking statements as a result of various important factors. Such forward-looking
68wzp5xm5v46296aje4sf50hqlod6frrc4zdri5kpqdo0v41nrza0
OCUL
9 Apr 24
by the Compensation Committee of Ocular and were made as inducements material to Dr. Zhu's acceptance of employment with Ocular under Ocular's 2019
35sl3 6ju5o4vyg2tchnklpl9k4rne017wjk
OCUL
6 Apr 24
the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking
- Prev
- 1
- Next